News – Page 92 – Endpoints News

Novo Nordisk to decrease some insulin pen manufacturing, transition supply

7 months ago

WeightWatchers replaces CEO who spearheaded its push into prescription weight loss drugs

7 months ago

FDA approves Dupixent in COPD, opening ‘next chapter’ for Sanofi and Regeneron’s bestseller

7 months ago

Travere halts Phase 3 inherited disease trial due to manufacturing scale-up issue

7 months ago

Cassava and its former execs settle SEC charges for ‘misleading’ Alzheimer’s drug data

7 months ago

Steve Davis leaves Acadia, replaced by Bristol Myers alum; Former J&J exec to lead R&D at Novavax

7 months ago

The worst is over for digital health funding, PitchBook report says

7 months ago

The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry

7 months ago

Endpoints 11 winner MediLink Therapeutics: China startup helps power the ADC renaissance

7 months ago

Endpoints 11 winner Lifordi Immunotherapeutics: Using antibodies to deliver potent steroids directly to immune cells

7 months ago

Endpoints 11 winner Iambic Therapeutics: Entering the ‘show-me’ era for AI

7 months ago

Endpoints 11 winner Cardurion Pharmaceuticals: A shot at one of heart disease’s 'undruggable' targets

7 months ago

Endpoints 11 winner Ascidian Therapeutics: A search-and-replace technology comes to RNA

7 months ago

Endpoints 11 winner Metsera: Clive Meanwell wagers on obesity after Medicines Company success

7 months ago

Endpoints 11 winner Xaira Therapeutics: Biotech’s largest AI bet with A-list backers

7 months ago

Endpoints 11 winner Formation Bio: A Silicon Valley-fueled unicorn aiming to be the next Roivant — or more

7 months ago

Endpoints 11 winner Capstan Therapeutics: Trying to win the in vivo CAR-T race

7 months ago

Endpoints 11 winner Mirador Therapeutics: Applying precision medicine to immune disease

7 months ago

Endpoints 11 winner Seaport Therapeutics: The Karuna team is back with another big bet in neuroscience

7 months ago

FDA approves Bristol Myers and Karuna's schizophrenia drug, in milestone for psychiatry

7 months ago

FDA lifts hold on Biomea’s diabetes trials

7 months ago

AstraZeneca's lung cancer blockbuster Tagrisso wins label expansion in early-stage EGFR patients

7 months ago

Insilico Medicine, an early force in AI-driven drug R&D, lets IPO plans peter out for second year in a row

7 months ago

Genentech's Gazyva hits primary endpoint in late-stage kidney disease trial

7 months ago

First page Previous page 89 90 919293 94 95 Next page Last page